1. The Role of Population Pharmacokinetics in Drug Development in Light of the Food and Drug Administration’s ‘Guidance for Industry: Population Pharmacokinetics’

   • Paul J. Williams
   • Ene I. Ette

   Leading Article 30 September 2012 Pages: 385 - 395

2. Clinical Pharmacokinetics of Pravastatin

   • Tomomi Hatanaka

   Review Articles 30 September 2012 Pages: 397 - 412

   

3. Clinical Pharmacokinetics of Reboxetine, a Selective Norepinephrine Reuptake Inhibitor for the Treatment of Patients with Depression

   • Joseph C. Fleishaker

   Review Articles 30 September 2012 Pages: 413 - 427

   

4. Clinical and Preclinical Pharmacokinetics of Raltitrexed

   • Stephen J. Clarke
   • Philip J. Beale
   • Laurent P. Rivory

   Review Articles 30 September 2012 Pages: 429 - 443

   

5. Monitoring Antiplatelet Therapy

   • Debabrata Mukherjee
   • David J. Moliterno

   Review Articles 30 September 2012 Pages: 445 - 458

   

6. Chiral Bioequivalence

   • Joseph P. Boni
   • Joan M. Korth-Bradley
   • Leslie Z. Benet

   Original Research Article 30 September 2012 Pages: 459 - 469